Quantum Computing (QUBT): Revisiting Valuation After a Strong Multi‑Year Run and Recent Pullback

Quantum Computing (QUBT) has been on a choppy path, with the stock sliding over the past month even after a strong 1 year run, creating a challenging entry point for investors.

See our latest analysis for Quantum Computing.

The recent pullback, including a 9.51% 30 day share price return and a softer 90 day stretch, contrasts sharply with Quantum Computing’s 61.92% 1 year total shareholder return and exceptional 3 year total shareholder return of 532.51%. This suggests momentum is cooling after a powerful run.

If QUBT’s swings have you rethinking concentration risk, this could be a smart moment to scout high growth tech and AI stocks for other high potential names across the broader tech and AI space.

With the share price now trading well below analyst targets despite explosive multi year returns, investors face a key question: is Quantum Computing still misunderstood and undervalued, or is the market already pricing in its future growth?

Advertisement

Price to Book of 3.3x: Is it justified?

Based on its current price to book ratio of 3.3 times and last close of $12.84, Quantum Computing screens as expensive against peers despite its pullback.

The price to book multiple compares a company’s market value to its net assets, a common yardstick for early stage, asset heavy or pre profit tech names where earnings are not yet a reliable guide.

For Quantum Computing, a 3.3 times price to book suggests investors are assigning a premium to its balance sheet and future potential, even though the company is unprofitable and forecast to remain so over the next three years.

Relative to the broader US tech industry average price to book of 2.4 times, that premium is significant and signals the market is pricing in far stronger growth and execution than the typical peer.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price to Book of 3.3x (OVERVALUED)

However, persistent losses and a steep valuation multiple mean that any delay in commercial adoption or contract wins could quickly erode recent shareholder gains.

Find out about the key risks to this Quantum Computing narrative.

Build Your Own Quantum Computing Narrative

If you want to dig into the numbers yourself or think the story looks different from this view, you can build your own in minutes, Do it your way.

A great starting point for your Quantum Computing research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.

Ready to level up your stock shortlist?

Before you make your next move on Quantum Computing, lock in a stronger opportunity set by running a quick screen for fresh, data backed ideas today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Quantum Computing might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:QUBT

Quantum Computing

An integrated photonics company, provides quantum machines to commercial and government markets in the United States.

Flawless balance sheet with high growth potential.

Advertisement

Weekly Picks

CE
Ceazar
SPAI.F logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:US$3.8756.3% undervalued
13 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
211 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
17 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

PR
PrashhD
AURIONPRO logo
PrashhD on Aurionpro Solutions ·

Aurionpro Solutions: Is the Market Mispricing One of India's Most Interesting Fintech Product Companies?

Fair Value:₹1k27.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NE
LOT logo
newsfinder11221 on Lotus Technology ·

Lotus Technology: A Technology-Driven Luxury EV Brand with a Promising Turnaround Story

Fair Value:US$2.462.9% undervalued
1 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative
ON
AIIO logo
Ontological on Robo.ai ·

Robo.ai and Abu Dhabi Enterprise Jointly Establish AI Industrial Group Alif Holding to Serve Infrastructure, Government and Industrial Secto

Fair Value:US$0.0026117.2k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
93 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
207 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0